Searched for
CHEAP DRUGS
Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- Think the World Cup is just about football? This podcast says otherwiseThe World Cup is a global spectacle. However, criminal cartels are planning to profit from the upcoming tournament. A podcast explores this...
- This 'Red Card' shakes up Mizoram's prohibition policyMizoram's ZPM government will now issue permits for liquor consumption on medical grounds. Residents can apply for a 'Red Card' with a pres...
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
- Pune hooch tragedy: Toll rises to 17 as 22 police, excise officials suspended, methanol supplier tracedA spurious liquor tragedy in Pune and Pimpri Chinchwad has claimed 17 to 18 lives. Most victims were daily wage labourers. The state govern...
- In 1859, Robert Chesebrough saw oil workers scraping sticky rod wax from drilling rigs, and it wasn’t just waste: It became VaselineA chemist named Robert Chesebrough discovered petroleum jelly in the 1800s. He saw value in a sticky wax that oil workers discarded. Cheseb...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Endurance, the new superpower of the battlefieldThe economy of attrition is the big new reality of the battlefield. Expensive defences are badly struggling against waves of cheap drones a...
- Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...
- Pharma industry seeks relief from price cap rule for cheap drugsIndia’s FoPE seeks a 10-year exemption for patented and low-cost drugs from price controls. Requests include DPCO and 12% GST adjustments d...
- J&J, Lupin cut prices for tuberculosis drug in lower-income countriesJohnson & Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and mi...
- Exclude cheap drugs from price control: IPASudarshan Jain, secretary general of IPA, in an interview to ET said "We are not against price controls; what we are saying is that the gov...
- India, Brazil & China defend generic drugs at WTOIndia, Brazil and China, however, argued that infringing intellectual property rights should not be confused with sub-standard products.
- EU pact won’t hurt genericsThe proposed India-EU trade and investment agreement will not curtail India’s right to produce and export cheap life-saving medicines.
- Merck arm to sell cheap diabetes drugThis is perhaps one of the few instances where a drug is cheaper in India, as against its price in other developed markets. (Januvia is pri...
- HC comment may cure drug mkt of pricing illsThe recent Delhi High Court observation suggesting that access to cheap drugs is a fundamental right is likely to have a major impact on th...
- HC ruling to affect access to cheap drugsAfter months of hearings, the Madras High Court is expected to rule next week on a case that could have a profound impact on patients’ acce...
- Paswan has cheap drugs for poorEven as he rattled off growth and productivity figures for steel, reeled off demand and supply statistics and invited investments to India.
Load More
